Mutational signature-based classification uncovers emerging oral cancer subtypes with distinct molecular patterns

Abstract

Tobacco use, alcohol consumption, and infection with human papilloma virus (HPV) are well-established risk factors for head and neck squamous cell carcinomas (HNSCC). However, the incidence of oral cancer, particularly in the mobile tongue, has been rising in non-smoker/non-drinker and HPV-negative patients, suggesting the emergence of a new clinical entity. To understand in molecular terms this subtype of oral cavity squamous cell carcinomas (OCSCC) with no-identified risk factor (NIRF), we analyzed the available public head and neck cancer multi-omics data. We identified mutational signatures that stratified 253 OCSCC and 94 laryngeal cancer cases, used as tobacco-only-related controls, according to their clinico-pathological characteristics. We show that tobacco, depending on the anatomical site, triggers distinct mutational processes and further demonstrate that the single-base-substitution (SBS) signature SBS16 in OCSCC is associated with tobacco smoking, reflecting the combined effects of smoking and drinking. Importantly, we identified a tongue cancer-enriched NIRF OCSCC subgroup exhibiting significantly increased endogenous clock-like mutagenesis, while another NIRF subgroup manifested with elevated apolipoprotein B mRNA editing enzyme catalytic polypeptide-like (APOBEC)-associated mutagenesis. Both NIRF OCSCC subgroups harbored specific cancer driver mutations and distinct methylation patterns, which differed from those observed in OCSCC linked to traditional HNSCC risk factors, reflecting unique molecular programs underlying disease development. Specifically, NIRF-OSCC exhibited pronounced immune evasion strategies and antimicrobial transcriptomic responses. Our study presents the first molecular and genomic characterization of the emerging NIRF OCSCC subtype likely driven by increased endogenous mutagenesis and responses to microbial insults. These findings warrant future detailed investigations into etiology and have implications for clinical management and cancer prevention.

References

[1] Oral Cancer Incidence (New Cases) by Age, Race, and Gender. National Institute of Dental and Craniofacial Researchhttps://www.nidcr.nih.gov/research/data-statistics/oral-cancer/incidence.

[2] Nokovitch L, et al. . Oral cavity squamous cell carcinoma risk factors: state of the art. J. Clin. Med., 2023, 12: 3264

[3] Johnson DE, et al. . Head and neck squamous cell carcinoma. Nat. Rev. Dis. Prim., 2020, 6: 1-22

[4] Menezes FDS, Fernandes GA, Antunes JLF, Villa LL, Toporcov TN. Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies. Oral. Oncol., 2021, 115: 105177

[5] Mirghani H, Amen F, Moreau F, Lacau St Guily J. Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma?. Oral. Oncol., 2015, 51: 229-236

[6] Kawakita D, et al. . Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan. Cancer Med., 2022, 11: 1553-1560

[7] Satgunaseelan L, et al. . The incidence of squamous cell carcinoma of the oral tongue is rising in young non-smoking women: An international multi-institutional analysis. Oral. Oncol., 2020, 110 104875

[8] Deneuve S, et al. . Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France. Int. J. Cancer, 2022, 150: 1301-1309

[9] Kim Y-J, Kim JH. Increasing incidence and improving survival of oral tongue squamous cell carcinoma. Sci. Rep., 2020, 10 7877

[10] Ng JH, Iyer NG, Tan M-H, Edgren G. Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study. Head. Neck, 2017, 39: 297-304

[11] Cohen Goldemberg D, de Araújo LHL, Antunes HS, de Melo AC, Santos Thuler LC. Tongue cancer epidemiology in Brazil: incidence, morbidity and mortality. Head. Neck, 2018, 40: 1834-1844

[12] Li R, Koch WM, Fakhry C, Gourin CG. Distinct epidemiologic characteristics of oral tongue cancer patients. Otolaryngol. Head. Neck Surg., 2013, 148: 792-796

[13] Braakhuis BJM, Leemans CR, Visser O. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral. Oncol., 2014, 50: 670-675

[14] Dahlstrom, K. R. et al. Squamous cell carcinoma of the head and neck in never smoker–never drinkers: A descriptive epidemiologic study. Head & Neck30, 75–84.

[15] Deneuve, S. et al. Oral tongue squamous cell carcinomas in young patients according to their smoking status: a GETTEC study. Eur. Arch. Otorhinolaryngol.https://doi.org/10.1007/s00405-021-06793-7 (2021).

[16] Valero C, et al. . Young non-smokers with oral cancer: What are we missing and why?. Oral. Oncol., 2022, 127 105803

[17] Volkova NV, et al. . Mutational signatures are jointly shaped by DNA damage and repair. Nat. Commun., 2020, 11 2169

[18] Islam, S. M. A. et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genomics 100179 https://doi.org/10.1016/j.xgen.2022.100179 (2022).

[19] Alexandrov LB, et al. . The repertoire of mutational signatures in human cancer. Nature, 2020, 578: 94-101

[20] Degasperi A, et al. . Substitution mutational signatures in whole-genome–sequenced cancers in the UK population. Science, 2022, 376: abl9283

[21] Campbell BR, et al. . The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma. Cancer, 2021, 127: 544-553

[22] Gillison ML, et al. . Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. Genome Res., 2019, 29: 1-17

[23] Plath M, et al. . Unraveling most abundant mutational signatures in head and neck cancer. Int. J. Cancer, 2021, 148: 115-127

[24] South AP, et al. . Mutation signature analysis identifies increased mutation caused by tobacco smoke associated DNA adducts in larynx squamous cell carcinoma compared with oral cavity and oropharynx. Sci. Rep., 2019, 9 19256

[25] Alexandrov LB, et al. . Mutational signatures associated with tobacco smoking in human cancer. Science, 2016, 354: 618-622

[26] Faden DL, et al. . Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma. Oral. Oncol., 2017, 74: 8-14

[27] Bosetti C, et al. . Cancer of the larynx in non-smoking alcohol drinkers and in non-drinking tobacco smokers. Br. J. Cancer, 2002, 87: 516-518

[28] Henderson S, Chakravarthy A, Su X, Boshoff C, Fenton TR. APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development. Cell Rep., 2014, 7: 1833-1841

[29] Pickering CR, et al. . Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clin. Cancer Res, 2014, 20: 3842-3848

[30] Vossen DM, et al. . Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer. Oral. Oncol., 2018, 81: 35-44

[31] Jéhannin-Ligier K, et al. . Incidence trends for potentially human papillomavirus-related and -unrelated head and neck cancers in France using population-based cancer registries data: 1980-2012. Int J. Cancer, 2017, 140: 2032-2039

[32] Chan K, et al. . An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat. Genet., 2015, 47: 1067-1072

[33] Letouzé E, et al. . Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis. Nat. Commun., 2017, 8 1315

[34] Ko JM-Y, et al. . Clonal relationship and alcohol consumption-associated mutational signature in synchronous hypopharyngeal tumours and oesophageal squamous cell carcinoma. Br. J. Cancer, 2022, 127: 2166-2174

[35] Moody S, et al. . Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat. Genet., 2021, 53: 1553-1563

[36] Chang J, et al. . Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat. Commun., 2017, 8 15290

[37] Li XC, et al. . A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma. Ann. Oncol., 2018, 29: 938-944

[38] Torrens, L. et al. The complexity of tobacco smoke-induced mutagenesis in head and neck cancer. Nat. Genet. 1–13 https://doi.org/10.1038/s41588-025-02134-0 (2025).

[39] Pinyol R, et al. . Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J. Hepatol., 2021, 75: 865-878

[40] Nguyen L, et al. . Precancerous liver diseases do not cause increased mutagenesis in liver stem cells. Commun. Biol., 2021, 4: 1301

[41] Ng SWK, et al. . Convergent somatic mutations in metabolism genes in chronic liver disease. Nature, 2021, 598: 473-478

[42] Ma H-Y, et al. . IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease. J. Hepatol., 2020, 72: 946-959

[43] Brunner SF, et al. . Somatic mutations and clonal dynamics in healthy and cirrhotic human liver. Nature, 2019, 574: 538-542

[44] Dal Maso L, et al. . Combined effect of tobacco smoking and alcohol drinking in the risk of head and neck cancers: a re-analysis of case-control studies using bi-dimensional spline models. Eur. J. Epidemiol., 2016, 31: 385-393

[45] Yoshida K, et al. . Tobacco smoking and somatic mutations in human bronchial epithelium. Nature, 2020, 578: 266-272

[46] Wallenius K. Experimental oral cancer in the rat. With special reference to the influence of saliva. Acta Pathol. Microbiol Scand. Suppl., 1966, 180: 1-91

[47] Ames BN, McCann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test. Mutat. Res./Environ. Mutagen. Relat. Subj., 1975, 31: 347-363

[48] Lekholm U, Wallenius K. Experimental oral cancer in rats with xerostomia. Odontol. Rev., 1976, 27: 11-18

[49] Nishioka H, Nishi K, Kyokane K. Human saliva inactivates mutagenicity of carcinogens. Mutat. Res./Environ. Mutagen. Relat. Subj., 1981, 85: 323-333

[50] Dayar D, Hirshberg A, Kaplan I, Rotem N, Bodner L. Experimental tongue cancer in desalivated rats. Oral. Oncol., 1997, 33: 105-109

[51] Matsuo K, Palmer JB. Anatomy and physiology of feeding and swallowing – normal and abnormal. Phys. Med Rehabil. Clin. N. Am., 2008, 19: 691-707

[52] Roberts SA, et al. . An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet., 2013, 45: 970-976

[53] Burns MB, Temiz NA, Harris RS. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Genet., 2013, 45: 977-983

[54] Pecori R, Di Giorgio S, Paulo Lorenzo J, Nina Papavasiliou F. Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination. Nat. Rev. Genet., 2022, 23: 505-518

[55] Alexandrov LB, et al. . Clock-like mutational processes in human somatic cells. Nat. Genet., 2015, 47: 1402-1407

[56] Guo Q, et al. . The mutational signatures of formalin fixation on the human genome. Nat. Commun., 2022, 13 4487

[57] Moore, L. et al. The mutational landscape of human somatic and germline cells. Nature 1–6 https://doi.org/10.1038/s41586-021-03822-7 (2021).

[58] Abascal F, et al. . Somatic mutation landscapes at single-molecule resolution. Nature, 2021, 593: 405-410

[59] Tomkova M, et al. . Human DNA polymerase ε is a source of C>T mutations at CpG dinucleotides. Nat. Genet, 2024, 56: 2506-2516

[60] The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature, 2015, 517: 576-582

[61] Papillon-Cavanagh S, et al. . Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas. Nat. Genet., 2017, 49: 180-185

[62] Brennan K, Koenig JL, Gentles AJ, Sunwoo JB, Gevaert O. Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype. EBioMedicine, 2017, 17: 223-236

[63] Li Y, et al. . Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas. Mol. Cell, 2022, 82: 3901-3918.e7

[64] Brennan K, et al. . NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma. Sci. Rep., 2017, 7 17064

[65] Farhangdoost N, et al. . Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma. Cell Rep., 2021, 34 108769

[66] Peng P, et al. . Epigenetic remodeling under oxidative stress: Mechanisms driving tumor metastasis. MedComm. – Oncol., 2024, 3 e70000

[67] Zhu Z, Zhou Q, Guan P, Sun Y, Li G. Novel DNA methylation biomarkers in enhancer regions with chromatin interactions for diagnosis of non-small-cell lung cancer. MedComm. – Oncol., 2023, 2: e51

[68] Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell, 2015, 160: 48-61

[69] Poore GD, et al. . Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature, 2020, 579: 567-574

[70] Nejman D, et al. . The human tumor microbiome is composed of tumor-type-specific intracellular bacteria. Science, 2020, 368: 973-980

[71] Narunsky-Haziza L, et al. . Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell, 2022, 185: 3789-3806.e17

[72] Galeano Niño JL, et al. . Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature, 2022, 611: 810-817

[73] Gettinger S, et al. . Impaired HLA Class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer. Cancer Discov., 2017, 7: 1420-1435

[74] Buisson R, Lawrence MS, Benes CH, Zou L. APOBEC3A and APOBEC3B activities render cancer cells susceptible to ATR inhibition. Cancer Res, 2017, 77: 4567-4578

[75] Warren CJ, Santiago ML, Pyeon D. APOBEC3: Friend or Foe in Human Papillomavirus Infection and Oncogenesis?. Annu Rev. Virol., 2022, 9: 375-395

[76] Foy J-P, et al. . Arguments to support a viral origin of oral squamous cell carcinoma in non-smoker and non-drinker patients. Front Oncol., 2020, 10: 822

[77] Bullman S. The intratumoral microbiota: From microniches to single cells. Cell, 2023, 186: 1532-1534

[78] Cai L, et al. . Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma. NPJ Biofilms Microbiomes, 2024, 10 39

[79] Xue C, et al. . Current understanding of the intratumoral microbiome in various tumors. Cell Rep. Med., 2023, 4 100884

[80] Gihawi A, et al. . The landscape of microbial associations in human cancer. Sci. Transl. Med., 2025, 17 eads6166

[81] Ge Y, Lu J, Puiu D, Revsine M, Salzberg SL. Comprehensive analysis of microbial content in whole-genome sequencing samples from The Cancer Genome Atlas project. Sci. Transl. Med., 2025, 17: eads6335

[82] Campbell JD, et al. . Genomic, pathway network, and immunologic features distinguishing squamous carcinomas. Cell Rep., 2018, 23: 194-212.e6

[83] Senkin S. MSA: reproducible mutational signature attribution with confidence based on simulations. BMC Bioinforma., 2021, 22 540

[84] Martincorena I, et al. . Universal patterns of selection in cancer and somatic tissues. Cell, 2017, 171: 1029-1041.e21

[85] Wu T, et al. . clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation, 2021, 2100141

RIGHTS & PERMISSIONS

The Author(s)